Our results demonstrated that CLA-whey nanomicelles possess schistosomicidal and anti-pathology activities that were highly significantly enhanced by coupling of the antibodies to the surface of the micelles, with anti-SmI-CLA been accredited with the highest therapeutic potential against both early and late stages of the infection. The gene discussed is SELPLG; the disease is infection.